REFERENCES
2. Rostad H, Sørland SJ. Atrial septal defects of secundum type in patients less than 40 years of age: a follow-up study. Acta Med Scand Suppl 1981;209:29-35.
3. Shaalan A, Elrakhawy H, Alassal M, Wakeel E. Improvement after surgical closure of secundum atrial septal defects in adults. J Clin Exp Cardiolog 2017;8:2.
4. Post M. Association between pulmonary hypertension and an atrial septal defect. Neth Heart J 2013;21:331-2.
5. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900.
6. Kim NK, Park SJ, Choi JY. Transcatheter closure of atrial septal defect: does age matter? Korean Circ J 2011;41:633-8.
7. Kaplan S. Congenital heart disease in adolescents and adults. Natural and postoperative history across age groups. Cardiol Clin 1993;11:543-56.
8. Martin SS, Shapiro EP, Mukherjee M. Atrial septal defects-clinical manifestations, Echo assessment, and intervention. Clin Med Insights Cardiol 2015;8:93-8.
9. Dehghani H, Boyle AJ. Percutaneous device closure of secundum atrial septal defect in older adults. Am J Cardiovasc Dis 2012;2:133-42.
10. Eadie LA, King MW. Biotextiles for atrial septal defect repair. In: King MW, Gupta BS, Guidoin R, editors. Biotextiles as Medical Implants. Woodhead Publishing; 2013. pp. 536-62.
11. Cho MJ, Song J, Kim SJ, Choi EY, Lee SY, et al. Transcatheter closure of multiple atrial septal defects with the amplatzer device. Korean Circ J 2011;41:549-51.
12. Kijima Y, Taniguchi M, Akagi T. Catheter closure of coronary sinus atrial septal defect using Amplatzer Septal Occluder. Cardiol Young 2012;22:223-6.
13. van Velzen CL, Clur SA, Rijlaarsdam ME, Bax CJ, Pajkrt E, et al. Prenatal detection of congenital heart disease--results of a national screening programme. BJOG 2016;123:400-7.
14. Hanslik A, Pospisil U, Salzer-Muhar U, Greber-Platzer S, Male C. Predictors of spontaneous closure of isolated secundum atrial septal defect in children: a longitudinal study. Pediatrics 2006;118:1560-5.
15. Radzik D, Davignon A, van Doesburg N, Fournier A, Marchand T, et al. Predictive factors for spontaneous closure of atrial septal defects diagnosed in the first 3 months of life. J Am Coll Cardiol 1993;22:851-3.
16. McMahon C, Feltes T, Fraley J, Bricker J, Grifka R, et al. Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart 2002;87:256-9.
17. Lin KM, Liang CD, Chien SJ, Lin YJ, Lin IC, et al. Predictors for Regression of Large Secundum Atrial Septal Defects Diagnosed in Infancy. Acta Cardiol Sin 2013;29:82-7.
18. Webb G, Gatzoulis MA. Atrial septal defects in the adult: recent progress and overview. Circulation 2006;114:1645-53.
20. Le Gloan L, Legendre A, Iserin L, Ladouceur M. Pathophysiology and natural history of atrial septal defect. J Thorac Dis 2018;10:S2854-63.
21. Spies C, Hijazi ZM. Transcatheter closure of secundum atrial septal defects in the elderly. Korean Circ J 2009;39:47.
22. Schubert S, Peters B, Abdul-Khaliq H, Nagdyman N, Lange PE, et al. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv 2005;64:333-7.
23. Swan L, Varma C, Yip J, Warr M, Webb G, et al. Transcatheter device closure of atrial septal defects in the elderly: technical considerations and short-term outcomes. Int J Cardiol 2006;107:207-10.
24. Beitzke D, Wolf F, Edelhauser G, Lammer J, Loewe C. Right heart dilatation in adult congenital heart disease: imaging appearance on cardiac magnetic resonance. Br J Radiol 2011;84:188-93.
25. Elshershari H, Cao Q, Hijazi Z. Transcatheter device closure of atrial septal defects in patients older than 60 years of age: immediate and follow-up results. J Invasive Cardiol 2008;20:173-6.
26. Takaya Y, Akagi T, Kijima Y, Nakagawa K, Watanabe N, et al. Echocardiographic estimates of left ventricular diastolic dysfunction do not predict the clinical course in elderly patients undergoing transcatheter atrial septal defect closure: impact of early diastolic mitral annular velocity. J Interv Cardiol 2017;30:79-84.
27. Taniguchi M, Akagi T, Watanabe N, Okamoto Y, Nakagawa K, et al. Application of real-time three-dimensional transesophageal echocardiography using a matrix array probe for transcatheter closure of atrial septal defect. J Am Soc Echocardiogr 2009;22:1114-20.
28. Silvestry FE, Cohen MS, Armsby LB, Burkule NJ, Fleishman CE, et al. Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: from the american society of echocardiography and society for cardiac angiography and interventions. J Am Soc Echocardiogr 2015;28:910-58.
29. Johri AM, Witzke C, Solis J, Palacios IF, Inglessis I, et al. Real-time three-dimensional transesophageal echocardiography in patients with secundum atrial septal defects: outcomes following transcatheter closure. J Am Soc Echocardiogr 2011;24:431-7.
30. Perk G, Lang RM, Garcia-Fernandez MA, Lodato J, Sugeng L, et al. Use of real time three-dimensional transesophageal echocardiography in intracardiac catheter based interventions. J Am Soc Echocardiogr 2009;22:865-82.
31. Bishop KC, Kuller JA, Boyd BK, Rhee EH, Miller S, et al. Ultrasound examination of the fetal heart. Obstet Gynecol Surv 2017;72:54-61.
32. Cay N, Unal O, Ipek A, Ikiz SS, Balaban M, et al. Prenatal diagnosis of isolated ostium secundum defect by ultrasound in the second trimester. Am J Cardiol 2015;115:S135.
33. Persico N, Moratalla J, Lombardi C, Zidere V, Allan L, et al. Fetal echocardiography at 11-13 weeks by transabdominal high-frequency ultrasound. Ultrasound Obstet Gynecol 2011;37:296-301.
34. Erős FR, Beke A. Congenital fetal anomalies and the role of prenatal ultrasound. In: Tudorache S, editor. Congenital Anomalies-From the Embryo to the Neonate. IntechOpen; 2018.
35. Hafner E, Scholler J, Schuchter K, Sterniste W, Philipp K. Detection of fetal congenital heart disease in a low-risk population. Perinat Diagn 1998;18:808-15.
36. Rajiah P, Mak C, Dubinksy TJ, Dighe M. Ultrasound of fetal cardiac anomalies. AJR Am J Roentgenol 2011;197:W747-60.
37. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005;112:1063-72.
38. Acheampong B, Johnson JN, Hagler DJ, Cabalka AK, Cetta F, et al. Intracardiac echocardiography-guided device closure of non-PFO/ASD shunts. Struct Heart 2017;2:69-74.
39. Wildes D, Lee W, Haider B, Cogan S, Sundaresan K, et al. 4-D ICE: A 2-D array transducer with integrated ASIC in a 10-Fr Catheter for Real-Time 3-D intracardiac echocardiography. IEEE Trans Ultrason Ferroelectr Freq Control 2016;63:2159-73.
40. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019;73:e81-192.
41. Silversides CK, Dore A, Poirier N, Taylor D, Harris L, et al. Canadian cardiovascular society 2009 consensus conference on the management of adults with congenital heart disease: shunt lesions. Can J Cardiol 2010;26:e70-9.
42. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010;31:2915-57.
43. Murphy JG, Gersh BJ, McGoon MD, Mair DD, Porter C-bJ, et al. Long-term outcome after surgical repair of isolated atrial septal defect: follow-up at 27 to 32 years. N Engl J Med 1990;323:1645-50.
44. Udholm S, Nyboe C, Karunanithi Z, Christensen AI, Redington A, et al. Lifelong burden of small unrepaired atrial septal defect: results from the danish national patient registry. Int J Cardiol 2019;283:101-6.
45. Attie F, Rosas M, Granados N, Zabal C, Buendía A, et al. Surgical treatment for secundum atrial septal defects in patients > 40 years old: a randomized clinical trial. J Am Coll Cardiol 2001;38:2035-42.
46. Oster M, Bhatt AB, Zaragoza-Macias E, Dendukuri N, Marelli A. Interventional therapy versus medical therapy for secundum atrial septal defect: a systematic review (part 2) for the 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019;73:1579-95.
47. Nyboe C, Karunanithi Z, Nielsen-Kudsk JE, Hjortdal VE. Long-term mortality in patients with atrial septal defect: a nationwide cohort-study. Eur Heart J 2017;39:993-8.
48. Baruteau A, Jones MI, Riahi M, Nieves Velasco Forte M, Byrne N, et al. Early experience of transcatheter correction of superior sinus venosus atrial septal defect with partial anomalous pulmonary venous drainage. Arch Cardiovasc Dis 2019;11:129.
49. Riahi M, Velasco Forte MN, Byrne N, Hermuzi A, Jones M, et al. Early experience of transcatheter correction of superior sinus venosus atrial septal defect with partial anomalous pulmonary venous drainage. EuroIntervention 2018;14:868-76.
50. Mohammad Nijres B, Kenny D, Kazmouz S, Hijazi ZM. Transcatheter closure of unroofed coronary sinus using covered stents in an adult with drainage of the coronary sinus to the right ventricle after supra-annular tricuspid valve replacement. Catheter Cardiovasc Interv 2017;90:1154-7.
51. Roy M, Nandi D, Chattopadhyay A, Bandhyopadhyay B, Nayak HK. Transcatheter closure of coronary sinus atrial septal defect by Amplatzer septal occluder device. J Indian Coll Cardiol 2017;7:163-5.
52. Ooi YK, Kelleman M, Ehrlich A, Glanville M, Porter A, et al. Transcatheter versus surgical closure of atrial septal defects in children: a value comparison. JACC Cardiovasc Interv 2016;9:79-86.
53. Kotowycz MA, Therrien J, Ionescu-Ittu R, Owens CG, Pilote L, et al. Long-term outcomes after surgical versus transcatheter closure of atrial septal defects in adults. JACC Cardiovasc Interv 2013;6:497-503.
54. Garg G, Tyagi H, Radha AS. Transcatheter closure of sinus venosus atrial septal defect with anomalous drainage of right upper pulmonary vein into superior vena cava--an innovative technique. Catheter Cardiovasc Interv 2014;84:473-7.
55. Thakkar AN, Chinnadurai P, Breinholt JP, Lin CH. Transcatheter closure of a sinus venosus atrial septal defect using 3D printing and image fusion guidance. Catheter Cardiovasc Interv 2018;92:353-7.
56. Abdullah HAM, Alsalkhi HA, Khalid KA. Transcatheter closure of sinus venosus atrial septal defect with anomalous pulmonary venous drainage: innovative technique with long-term follow-up. Catheter Cardiovasc Interv 2019; doi: 10.1002/ccd.28364.
57. Franke J, Bertog SC, Sideris EB, Hofmann I, Wunderlich N, et al. Transcatheter patch closure of an atrial septal defect of sinus venosus type using the immediate release patch. Catheter Cardiovasc Interv 2015;86:154-9.
58. Sideris B, Sideris E, Calachanis M, Papantoniou V, Moulopoulos S. The immediate release patch in the correction of experimental atrial septal defects. Catheter Cardiovasc Interv 2010;76:572-7.
59. King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 1976;235:2506-9.
60. Babic UU, Grujicic S, Djurisic Z, Vucinic M. Transcatheter closure of atrial septal defects. Lancet 1990;336:566-7.
61. Nassif M, Abdelghani M, Bouma BJ, Straver B, Blom NA, et al. Historical developments of atrial septal defect closure devices: what we learn from the past. Expert Rev Med Devices 2016;13:555-68.
62. Aytemir K, Oto A, Ozkutlu S, Canpolat U, Kaya EB, et al. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results. Congenit Heart Dis 2013;8:418-27.
63. Wang JK, Chiu SN, Lin MT, Chen CA, Lu CW, et al. Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect in patients older than 40 years. Heart vessels 2017;32:467-73.
64. Alnasser S, Lee D, Austin PC, Labos C, Osten M, et al. Long term outcomes among adults post transcatheter atrial septal defect closure: Systematic review and meta-analysis. Int J Cardiol 2018;270:126-32.
65. Nicolay S, Salgado RA, Shivalkar B, Van Herck PL, Vrints C, et al. CT imaging features of atrioventricular shunts: what the radiologist must know. Insights imaging 2016;7:119-29.
66. White HD, Halpern EJ, Savage MP. Imaging of adult atrial septal defects with CT angiography. JACC Cardiovasc Imaging 2013;6:1342-5.
67. Khoshpouri P, Khoshpouri P, Bedayat A, Ansari-Gilani K, Chalian H. Interatrial septum: A pictorial review of congenital and acquired pathologies and their management. Clin Imaging 2019;55:53-64.
68. Song J, Kim Y, Aigerim T. Usefulness of cardiac computed tomography in transcatheter closure of atrial septal defect with amplatzer septal occluder. Russ J of Cardiol 2013;47:35-9.
69. Chia RC, Salazar P, Al-Yafi M, Romano S, Farzaneh-Far A. Secundum Atrial Septal Defect. QJM 2018;111:571-2.
70. Lairakdomrong K, Srimahachota S, Lertsapcharoen P, Chaipromprasit J, Boonyaratavej S, et al. Clinical results of large secundum atrial septal defect closure in adult using percutaneous transcatheter Cocoon atrial septal occluder. J Med Assoc Thai 2013;96:1127-34.
71. Thanopoulos BD, Biasco L, Dardas P, De Backer O, Avraamides P, et al. Catheter closure of atrial septal defects using the Cocoon septal occluder: preliminary results of a European multicenter study. Int J Cardiol 2014;177:418-22.
72. Mijangos-Vázquez R, García-Montes AJ, Soto-López EM, Guarner-Lans V, Zabal C. Atrial septal defect closure with the new Cardia Ultrasept II™ device with interposed Goretex patch: Mexican experience-has the perforation of Ivalon’s membrane been solved? Cardiol Young 2018;28:709-14.
73. Bartel T, Bonaros N, Muller S. Device failure weeks to months after transcatheter closure of secundum type atrial septal defects. Heart 2010;96:1603.
74. Aubry P, Brochet E, du Fretay XH, Bouton-Brochet S, Ibrahim H, et al. Early malfunction of polyvinyl alcohol membrane-covered atrial septal defect closure devices. Circ Cardiovasc Interv 2014;7:721-2.
75. Bozyel S, Sahin T, Dervis E, Aktas M, Saskin H. A massive left-to-right shunt due to delayed spontaneous perforation of polyvinyl alcohol membrane of atrial septal occluder. Turk Kardiyol Dern Ars 2017;45:541-4.
76. Chamie F, Maia J, Giuliano LC. Device-in-device: a transcatheter alternative to surgical explantation of a failing atrial septal defect intracardiac prosthesis. Catheter Cardiovasc Interv 2016;88:239-43.
77. Peirone A, Contreras A, Ferrero A, da Costa RN, Pedra SF, et al. Immediate and short-term outcomes after percutaneous atrial septal defect closure using the new nit-occlud ASD-R device. Catheter Cardiovasc Interv 2014;84:464-70.
78. Bulut MO, Yucel IK, Kucuk M, Balli S, Basar EZ, et al. Initial experience with the Nit-Occlud ASD-R: short-term results. Pediatr Cardiol 2016;37:1258-65.
79. Astarcioglu MA, Kalcik M, Sen T, Aykan AC, Gokdeniz T, et al. Ceraflex versus Amplatzer occluder for secundum atrial septal defect closure. Multicenter clinical experience. Herz 2015;40 Suppl 2:146-50.
80. Apostolopoulou SC, Tsoutsinos A, Laskari C, Kiaffas M, Rammos S. Large single centre experience with the Cera and CeraFlex occluders for closure of interatrial communications: usefulness of the flexible rotation feature. Cardiovasc Interv Ther 2018;33:70-6.
81. Kenny D, Eicken A, Dahnert I, Boudjemline Y, Sievert H, et al. A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects. Catheter Cardiovasc Interv 2019;93:316-21.
82. Haas NA, Soetemann DB, Ates I, Baspinar O, Ditkivskyy I, et al. Closure of secundum atrial septal defects by using the occlutech occluder devices in more than 1300 patients: the IRFACODE project: a retrospective case series. Catheter Cardiovasc Interv 2016;88:571-81.
83. Godart F, Houeijeh A, Recher M, Francart C, Polge AS, et al. Transcatheter closure of atrial septal defect with the Figulla® ASD Occluder: a comparative study with the Amplatzer® Septal Occluder. Arch Cardiovasc Dis 2015;108:57-63.
84. Roymanee S, Promphan W, Tonklang N, Wongwaitaweewong K. Comparison of the Occlutech® Figulla® septal occluder and Amplatzer® septal occluder for atrial septal defect device closure. Pediatr Cardiol 2015;36:935-41.
85. Kim AY, Jung SY, Chang JY, Jung JW, Choi JY. Early to mid-term follow-up outcomes of percutaneous closure of atrial septal defects using recent generation devices: a single-center experience. Korean Circ J 2019;49:326-35.
86. O’Byrne ML, Glatz AC, Gillespie MJ. Transcatheter device closure of atrial septal defects: more to think about than just closing the hole. Curr Opin Cardiol 2018;33:108-16.
87. de Hemptinne Q, Horlick EM, Osten MD, Millan X, Tadros VX, et al. Initial clinical experience with the GORE® CARDIOFORM ASD occluder for transcatheter atrial septal defect closure. Catheter Cardiovasc Interv 2017;90:495-503.
88. Grohmann J, Wildberg C, Zartner P, Abu-Tair T, Tarusinov G, et al. Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients. Catheter Cardiovasc Interv 2017;89:E226-32.
89. Turner DR, Owada CY, Sang CJ Jr, Khan M, Lim DS. Closure of secundum atrial septal defects with the AMPLATZER septal occluder: a prospective, multicenter, post-approval study. Circ Cardiovasc Interv 2017;10:e004212.
90. Spies C, Timmermanns I, Schräder R. Transcatheter closure of secundum atrial septal defects in adults with the Amplatzer septal occluder: intermediate and long-term results. Clin Res Cardiol 2007;96:340.
91. Tomar M, Khatri S, Radhakrishnan S, Shrivastava S. Intermediate and long-term followup of percutaneous device closure of fossa ovalis atrial septal defect by the Amplatzer septal occluder in a cohort of 529 patients. Ann Pediatr Cardiol 2011;4:22-7.
92. Villablanca PA, Briston DA, Rodés-Cabau J, Briceno DF, Rao G, et al. Treatment options for the closure of secundum atrial septal defects: a systematic review and meta-analysis. Int J Cardiol 2017;241:149-55.
93. Akagi T. Catheter intervention for adult patients with congenital heart disease. J Cardiol 2012;60:151-9.
94. Maeno YV. Dynamic morphology of the secundum atrial septal defect evaluated by three dimensional transoesophageal echocardiography. Heart 2000;83:673-7.
95. Acar P, Saliba Z, Bonhoeffer P, Aggoun Y, Bonnet D, et al. Influence of atrial septal defect anatomy in patient selection and assessment of closure with the Cardioseal device; a three-dimensional transoesophageal echocardiographic reconstruction. Eur Heart J 2000;21:573-81.
96. Yang MC, Wu JR. Recent review of transcatheter closure of atrial septal defect. Kaohsiung J Med Sci 2018;34:363-9.
97. Boon I, Vertongen K, Paelinck BP, Demulier L, Van Berendoncks A, et al. How to Size ASDs for Percutaneous Closure. Pediatr Cardiol 2018;39:168-75.
98. Yan C, Wang C, Pan X, Li S, Song H, et al. Three-dimensional printing assisted transcatheter closure of atrial septal defect with deficient posterior-inferior rim. Catheter Cardiovasc Interv 2018;92:1309-14.
99. Amedro P, Bayburt S, Assaidi A, Kreitmann B, Habib G, et al. Should transcatheter closure of atrial septal defects with inferior-posterior deficient rim still be attempted? J Thorac Dis 2019;11:708-16.
100. Levi DS, Moore JW. Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv 2004;61:543-7.
101. Rosenfeld HM, van der Velde ME, Sanders SP, Colan SD, Parness IA, et al. Echocardiographic predictors of candidacy for successful transcatheter atrial septal defect closure. Cathet Cardiovasc Diagn 1995;34:29-34.
102. Ramalingam R, Patil S, Setty N, Kharge J, Puttegowda B, et al. Tough, but not impossible-Retrieval of large atrial septal occluder devices embolized to left atrium. Interv Med Appl Sci 2017;9:42-6.
103. Nakagawa K, Akagi T, Taniguchi M, Kijima Y, Goto K, et al. Transcatheter closure of atrial septal defect in a geriatric population. Catheter Cardiovasc Interv 2012;80:84-90.
104. Agarwal S, Sud K, Menon V. Nationwide hospitalization trends in adult congenital heart disease across 2003-2012. J Am Heart Assoc 2016;5:e002330.
105. Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the US. J Am Coll Cardiol 2009;54:460-7.
106. Burchill LJ, Gao L, Kovacs AH, Opotowsky AR, Maxwell BG, et al. Hospitalization trends and health resource use for adult congenital heart disease-related heart failure. J Am Heart Assoc 2018;7:e008775.
107. Khan A, Tan J, Li W, Dimopoulos K, Spence M, et al. The impact of transcatheter atrial septal defect closure in the older population: a prospective study. JACC Cardiovasc Interv 2010;3:276-81.
108. Komar M, Przewlocki T, Olszowska M, Sobien B, Podolec P. The benefit of atrial septal defect closure in elderly patients. Clin Interv Aging 2014;9:1101.
109. Thilén M, Christersson C, Dellborg M, Mattsson E, Trzebiatowska-Krzynska A, et al. Catheter closure of atrial septal defect in the elderly (≥ 65 years). A worthwhile procedure. Int J Cardiol 2016;218:25-30.
110. Okamoto H. .
111. Faccini A, Butera G. Atrial septal defect (ASD) device trans-catheter closure: limitations. J Thorac Dis 2018;10:S2923-30.
112. Ewert P, Berger F, Nagdyman N, Kretschmar O, Dittrich S, et al. Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure? Catheter Cardiovasc Interv 2001;52:177-80.
113. Miranda WR, Hagler DJ, Reeder GS, Warnes CA, Connolly HM, et al. Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction: Hemodynamic and clinical findings. Catheter Cardiovasc Interv 2019;93:1069-75.
114. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958;18:533-47.
115. Heath D, Helmholz HF Jr, Burchell HB, Dushane JW, Kirklin JW, et al. Relation between structural change in the small pulmonary arteries and the immediate reversibility of pulmonary hypertension following closure of ventricular and atrial septal defects. Circulation 1958;18:1167-74.
116. Yong G, Khairy P, De Guise P, Dore A, Marcotte F, et al. Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study. Circ Cardiovasc Interv 2009;2:455-62.
117. Horer J, Eicken A, Muller S, Schreiber C, Cleuziou J, et al. Risk factors for prolonged intensive care treatment following atrial septal defect closure in adults. Int J Cardiol 2008;125:57-61.
118. Zwijnenburg R, Baggen V, Witsenburg M, Roos-Hesselink J, Van Den Bosch A. Prediction of pulmonary hypertension long-term after atrial septal defect closure. Eur Heart J 2017;38.
119. Kijima Y, Akagi T, Takaya Y, Akagi S, Nakagawa K, et al. Treat and repair strategy in patients with atrial septal defect and significant pulmonary arterial hypertension. Circulation 2015;80:227-34.
120. Kimura M, Tamura Y, Takei M, Yamamoto T, Ono T, et al. Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study. BMC Pulm Med 2015;15:62.
121. Li Q, Dimopoulos K, Zhang C, Zhu Y, Liu Q, et al. Acute effect of Inhaled Iloprost in children with pulmonary arterial hypertension associated with simple congenital heart defects. Pediatr Cardiol 2018;39:757-62.
122. Brida M, Gatzoulis MA. Pulmonary arterial hypertension in adult congenital heart disease. Heart 2018;104:1568-74.
123. Bradley EA, Chakinala M, Billadello JJ. Usefulness of medical therapy for pulmonary hypertension and delayed atrial septal defect closure. Am J Cardiol 2013;112:1471-6.
124. Jalal Z, Hascoet S, Baruteau AE, Iriart X, Kreitmann B, et al. Long-term complications after transcatheter atrial septal defect closure: a review of the medical literature. Can J Cardiol 2016;32:1315 e11-8.
125. Mallula K, Amin Z. Recent changes in instructions for use for the Amplatzer atrial septal defect occluder: how to incorporate these changes while using transesophageal echocardiography or intracardiac echocardiography? Pediatr Cardiol 2012;33:995-1000.
126. Amin Z. Echocardiographic predictors of cardiac erosion after Amplatzer septal occluder placement. Catheter Cardiovasc Interv 2014;83:84-92.
127. Jung SY, Choi JY. Transcatheter closure of atrial septal defect: principles and available devices. J Thorac Dis 2018;10:S2909-22.
128. McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z. Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects: a case-control study. Circulation 2016;133:1738-46.
129. Narin N, Baykan A, Argun M, Ozyurt A, Pamukcu O, et al. New modified balloon-assisted technique to provide appropriate deployment in the closure of large secundum atrial septal defect using amplatzer septal occluder in children. J Invasive Cardiol 2014;26:597-602.
130. Al-Qbandi MH, Al-Bannai OA, Behbehani FQ. .
131. Yucel IK, Balli S, Kucuk M, Celebi A. Use of steerable delivery catheter to successfully deliver a Ceraflex septal occluder to close an atrial septal defect in a child with interrupted inferior vena cava with azygos continuation. Turk Kardiyol Dern Ars 2016;44:244-7.
132. Kudumula V, Stumper O, Noonan P, Mehta C, De Giovanni J, et al. Transcatheter retrieval of cardiovascular foreign bodies in children: a 15-year single centre experience. Pediatr Cardiol 2017;38:1183-90.
133. Herbert JT, Kertai MD. Transesophageal echocardiography use in diagnosis and management of embolized intravascular foreign bodies. Semin Cardiothorac Vasc Anesth 2018;22:100-3.
134. Shebani SO, Rehman R, Taliotis D, Magee A, Hayes NJ, et al. Techniques for transcatheter retrieval of the occlutech ASD device United Kingdom-European multicenter report. Catheter Cardiovasc Interv 2017;89:690-8.
135. Durmuş G, Kalyoncuoğlu M, Belen E, Can MM. Retrieval of Embolized Atrial Septal Defect Closure Device in the Left Iliac Artery. Am J Cardiol 2018;121:e156.
136. Crawford DA, Naidu SG, Shah AA, Davila VJ, Stone WM. Endovascular retrieval of an embolized atrial septal occluder device from the abdominal aorta. Vasc Endovascular Surg 2018;52:669-73.
137. Martins DS, Mendes IC, Silva JR, Anjos R. .
138. Pavithran S, Sivakumar K. A novel snare assistance safeguards against early embolization of devices and facilitates quick retrieval of malpositioned devices in atrial septal defects with deficient margins. Ann Pediatr Cardiol 2015;8:189-95.
139. Bhattacharyya S, Ilsley CD, Baltabaeva A. Disintegration of polyvinyl alcohol membrane covering atrial septal defect closure device. Eur Heart J Cardiovasc Imaging 2015;16:1153.
140. Teekakirikul P, Zhu W, Xu X, Smith AM, Wang C, et al. Identification of a novel sarcomeric TPM1 variant in familial atrial septal defect. Circulation 2018;138:A15276.
141. Su W, Wang RC, Lohano MK, Wang L, Zhu P, et al. Identification of two mutations in PCDHGA4 and SLFN14 genes in an atrial septal defect family. Curr Med Sci 2018;38:989-96.
142. Wang J, Luo J, Chen Q, Wang X, He J, et al. Identification of LBX2 as a novel causal gene of atrial septal defect. Int J cardiol 2018;265:188-94.
143. DeLaughter DM, Bick AG, Wakimoto H, McKean D, Gorham JM, et al. Single-cell resolution of temporal gene expression during heart development. Dev Cell 2016;39:480-90.
144. Bulatovic I, Mansson-Broberg A, Sylven C, Grinnemo KH. Human fetal cardiac progenitors: the role of stem cells and progenitors in the fetal and adult heart. Best Pract Res Clin Obstet Gynaecol 2016;31:58-68.
145. Hameed A, Duffy GP, Hasan B, Fatimi SH. Tissue engineered solutions for intracardiac septal defects: a large step forward in an unmet clinical need. Ann Surg 2017;265:e11-2.
146. Lang N, Pereira MJ, Lee Y, Friehs I, Vasilyev NV, et al. A blood-resistant surgical glue for minimally invasive repair of vessels and heart defects. Sci Transl Med 2014;6:218ra6.
147. Tang B, Su F, Sun X, Wu Q, Xing Q, et al. Recent development of transcatheter closure of atrial septal defect and patent foramen ovale with occluders. J Biomed Mater Res B Appl Biomater 2018;106:433-43.
